Pharmaceutical compositions containing at least one NSAID having increased bioavailability
US6017932A · kind A · utility
15Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1997 |
| Grant date | Jan 25, 2000 |
| Priority date | — |
| Expiry date | Dec 10, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel composition for increasing the bioavailability of Non-steroidal Anti-inflammatory Drugs (NSAIDs), particularly those belonging to the category which exhibits its activity by selectively inhibiting cyclooxygenases-II (COX-II) and/or lipooxygenases, is disclosed. The composition is characterized in having clinically significant increased bioavailability when compared to the known compositions of the drugs. The pharmaceutical compositions comprise NSAIDs and Piperine, as herein disclosed. Enhanced bioavailability of NSAIDs results in the reduction of both dosages and dose-related side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.